Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.43p
   
  • Change Today:
    -0.026p
  • 52 Week High: 3.96
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 3,614,132
  • Market Cap: £19.12m
  • RiskGrade: 340

Regulatory News

Strategic Investment from Prevail Partners, LLC 18-Sep-2023 07:00 RNS
Clinical Hold Lift Plan is accepted by FDA 14-Sep-2023 07:00 RNS
Full FDA Review for HEMO-CAR-T IND 10-Jul-2023 07:00 RNS
Result of Annual General Meeting 30-Jun-2023 16:07 RNS
Posting of Annual Report & Notice of AGM 02-Jun-2023 14:01 RNS
Clinical Hold on IND for HEMO-CAR-T 02-Jun-2023 11:24 RNS
Submission of IND for HEMO-CAR-T 09-May-2023 07:00 RNS
Equity Incentive Pool Increase and Option Grant 28-Apr-2023 10:05 RNS
Final Results for the Year Ended 31 December 2022 28-Apr-2023 07:00 RNS
Total Voting Rights 28-Feb-2023 07:00 RNS
Admission of Shares to Official List 07-Feb-2023 14:30 RNS
Second Price Monitoring Extn 26-Jan-2023 09:05 RNS
Price Monitoring Extension 26-Jan-2023 09:00 RNS
Placing to Raise £4,056,250 26-Jan-2023 07:00 RNS
Second Price Monitoring Extn 16-Jan-2023 16:40 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.43p
Change Today -0.026p
% Change -1.79 %
52 Week High 3.96
52 Week Low 1.23
Volume 3,614,132
Shares Issued 1,341.82m
Market Cap £19.12m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.26% below the market average50.26% below the market average50.26% below the market average50.26% below the market average50.26% below the market average
68.63% below the sector average68.63% below the sector average68.63% below the sector average68.63% below the sector average68.63% below the sector average
Price Trend
11.96% above the market average11.96% above the market average11.96% above the market average11.96% above the market average11.96% above the market average
39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:55 10,402 @ 1.43p
15:53 150,000 @ 1.41p
15:53 84,319 @ 1.41p
15:04 100,000 @ 1.43p
15:04 337 @ 1.40p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page